An enzymatic assay for monitoring serum, cerebrospinal fluid, and urine concentration of beta-lactam antibiotics.
August 29/October 24, 1984 An enzymatic assay for the determination of the concentrations of various beta-lactam antibiotics in serum, urine, and cerebrospinal fluid samples is described. Recently developed beta-lactam derivatives are used as competitive inhibitors of the breakdown of the labile coloured beta-lactam compound PADAC, which serves as the substrate for the various beta-lactamases. Under the conditions of the assay, there is effectively no interference due to the matrix. Moreover, the assay is not influenced by other antibiotics such as aminoglycosides, macrolides, ansamycines, tetracyclines, fusidic acid or fosfomycin. The C.V.s for within-run precision ranged from 3.7% to 4.4%, depending on the beta-lactam derivative. The sensitivity of the assay is at least comparable with that of conventional procedures. Excellent correlations were observed between the enzymatic and the microbiological procedures; correlation coefficients: r = 0.988 for 22 imipenem samples, r = 0.968 for 16 cefotaxime samples, and r = 0.989 for 16 piperacillin samples routinely sent to our laboratory.
D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid / Q000652:urine; D002511:Cephalosporins; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007202:Indicators and Reagents; D001618:beta-Lactamases
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D007202:Indicators and Reagents; C034313:pyridine-2-azo-4-dimethylaniline cephalosporin; D001618:beta-Lactamases